Cover

Hemodialysis

New Methods and Future Technology

Editor(s): Ronco C. (Vicenza) 
Rosner M.H. (Charlottesville, Va.) 
Table of Contents
Vol. 171, 2011
Section title: Lipid Disorders and Metabolism
Ronco C, Rosner MH (eds): Hemodialysis: New Methods and Future Technology. Contrib Nephrol. Basel, Karger, 2011, vol 171, pp 135–142
(DOI:10.1159/000327317)

Lipid Abnormalities in Patients with Chronic Kidney Disease

Keane W.F. · Tomassini J.E. · Neff D.R.
aUniversity of Minnesota School of Medicine, and bMerck Sharp & Dohme Corp., Whitehouse Station, N.J., USA

Do you have an account?

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger (new!)
  • Unrestricted printing, no saving restrictions for personal use
  • Reduced rates with a PPV account
read more

Direct: USD 33.00
Account: USD 23.00

Select

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Complete book

  • Immediate access to all parts of this book
  • Cover-to-cover formats may be available
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restriction for personal use
read more

Pricing depends on hard-cover price


Select


Article / Publication Details

First-Page Preview
Abstract of Lipid Disorders and Metabolism

Published online: 5/23/2011
Cover Date: 2011

Number of Print Pages: 8
Number of Figures: 2
Number of Tables: 1

ISBN: 978-3-8055-9771-5 (Print)
eISBN: 978-3-8055-9772-2 (Online)

Abstract

Cardiovascular disease is increased in patients with chronic kidney disease (CKD) and is the principle cause of morbidity and mortality in these patients. Dyslipidemia, while common in these patients, is usually not characterized by elevated cholesterol, except in those patients with massive proteinuria. Qualitatively, increased triglycerides and reduced high-density lipoproteins (HDL) are most frequently described. Extensive abnormalities in the metabolism of apolipoprotein (apo) B-containing lipoproteins have been demonstrated, including those derived from the gut (apoB-48) as well as those derived from hepatic synthesis (apoB-100). Decreased enzymatic delipidation, in addition to reduced receptor removal of these lipoproteins, results in increased concentrations of these apoB-containing moieties, and in particular, their atherogenic remnants. Abnormalities in apoA-containing lipoproteins are also present and these changes may contribute not only to the lower levels of HDL seen, but also to the proinflammatory state that is frequently present in CKD patients. As a result, therapeutic strategies designed to modify atherosclerotic-caused outcomes in CKD may require multiple approaches.


  

Author Contacts

William F. Keane, MD, 11000 Placida Road, Placida, FL 33946 (USA), Tel. +1 908 240 8763, E-Mail williamfkeane@comcast.net

  

Article Information

Number of Print Pages : 8

  

Publication Details

Book Serie: Contributions to Nephrology, Vol. 171, Year 2011

Editor(s): Ronco, C. (Vicenza)
ISSN: 0302-5144 (Print), eISSN: 1662-2782 (Online)

For additional information:
http://content.karger.com/ProdukteDB/produkte.asp?issn=0302-5144

Book Title: Hemodialysis (New Methods and Future Technology)

Editor(s): Ronco C, Rosner MH (eds)

For additional information:
http://content.karger.com/ProdukteDB/produkte.asp?issn=0302-5144&volume=171


Article / Publication Details

First-Page Preview
Abstract of Lipid Disorders and Metabolism

Published online: 5/23/2011
Cover Date: 2011

Number of Print Pages: 8
Number of Figures: 2
Number of Tables: 1

ISBN: 978-3-8055-9771-5 (Print)
eISBN: 978-3-8055-9772-2 (Online)


Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.